Frontlight ResearchEarly access
Active, not recruitingNo phase
BOLT-DVT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
Key facts
- Who runs it
- Penumbra Inc.
- Where
- Albuquerque, Ann Arbor, Belleville, Buffalo, Charleston, Chicago, Cincinnati, Dallas, Durham, East Lansing, Hackensack, Indianapolis, Jacksonville, Kingsport, La Mesa, Lafayette, Lakeland, Lancaster, Lexington, Long Beach, Los Angeles, Miami, Miami Beach, New York, Newark, Norfolk, Omaha, Philadelphia, Raleigh, Sarasota, Shreveport, St Louis, Stony Brook, Washington D.C., and Worcester, United StatesSee the 42 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 229 people enrolled
- Started
- 30 Sept 2021
- Expected to end
- Jan 2028
- Type of study
- Interventional
- Treatments tested
- Indigo Aspiration System
- Record updated
- 8 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Unilateral lower extremity DVT occlusion involving iliac and/or common femoral veins with up to 2 cm extension in the inferior vena cava (IVC) or femoral in combination with iliac veins, including patients with extension of clot into the contralateral common iliac vein Note: Patients with non-iliofemoral DVT in the contralateral limb, who do not require endovascular treatment, may be enrolled
- Acute thrombotic or thromboembolic occlusion with symptom duration of 14 days or less at presentation
- Frontline treatment with Indigo Aspiration System in the target venous segment per Investigator decision
- Patient is ≥18 years of age
- Informed consent is obtained per Institutional Review Board requirements
Who cannot take part
- In the index leg: prior DVT
- Prior stent in target venous segment
- Treatment of index DVT with thrombolytics within 14 days prior to index procedure
- Pulmonary embolism (PE) defined as either high (systolic blood pressure < 90 mmHg and/or patient on IV vasoactive medication to support blood pressure), or intermediate high-risk PE, as defined by the European Society Guideline on management of PE. Low risk PE and/or intermediate low risk PE can be enrolled
- Current participation in another investigational drug or device study that may confound the results of this study. Studies requiring extended follow-up for products that were investigational but have since become commercially available are not considered investigational studies
- Pre-existing malpositioned stent(s) that obstructs the ostium of the index iliac vein and contacts the vena cava wall as demonstrated by venography prior to the index procedure
- Known coagulation disorders both acquired (e.g., Heparin Induced Thrombocytopenia, etc.) or genetic (e.g., Factor V Leiden, etc.), thrombophilia, or hypercoagulable state
- Primary brain, metastatic cancer or marrow malignancies
- Other medical, behavioral, or psychological conditions that, in the opinion of the Investigator, precludes the patient from appropriate consent, could limit the patient's ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study
- Contraindication to systemic or therapeutic doses of anticoagulants
- Contraindication to iodinated contrast venography that cannot be adequately premedicated
- Complete infrarenal IVC occlusion
- Pregnant patients
- Life expectancy <1 year due to comorbidities
- Congenital anatomic anomalies of the IVC or iliac veins
Where in United States
- Lovelace HeartAlbuquerque, United States
- St. Joseph Mercy Ann Arbor HospitalAnn Arbor, United States
- University of MichiganAnn Arbor, United States
- Protestant Memorial Medical Center, IncBelleville, United States
- Kaleida University at BuffaloBuffalo, United States
- MUSCCharleston, United States
- Northwestern MemorialChicago, United States
- Rush University Medical CenterChicago, United States
- Christ CincinnatiCincinnati, United States
- TriHealthCincinnati, United States
- BUMC - Dallas (Scott & White)Dallas, United States
- Duke University Medical CenterDurham, United States
- McLaren Greater LansingEast Lansing, United States
- Hackensack Medical CenterHackensack, United States
- Indiana University HealthIndianapolis, United States
- St. VincentIndianapolis, United States
- Memorial JacksonvilleJacksonville, United States
- Holston Valley MedicalKingsport, United States
- Sharp GrossmontLa Mesa, United States
- Lafayette General/Cardiovascular Institute of the SouthLafayette, United States
- Radiology and Imaging SpecialistsLakeland, United States
- Lancaster General HospitalLancaster, United States
- University of KentuckyLexington, United States
- Long Beach Medical CenterLong Beach, United States
- UCLALos Angeles, United States
- Baptist of MiamiMiami, United States
- Mount Sinai MiamiMiami Beach, United States
- Lenox Hill HospitalNew York, United States
- Mount Sinai (NY)New York, United States
- NYUNew York, United States
- Weill Cornell MedicineNew York, United States
- Christiana CareNewark, United States
- SentaraNorfolk, United States
- Nebraska MethodistOmaha, United States
- UPennPhiladelphia, United States
- NC Heart and Vascular ResearchRaleigh, United States
- Sarasota MemorialSarasota, United States
- LSU Hospital ShreveportShreveport, United States
- Jewish Barnes HospitalSt Louis, United States
- Stony Brook UniversityStony Brook, United States
- MedStar WashingtonWashington D.C., United States
- Umass Memorial Medical CenterWorcester, United States
About the trial
What the trial wants to find out
The objective of this study is to demonstrate the safety and efficacy of the Indigo Aspiration system for percutaneous mechanical thrombectomy in a population presenting with obstruction due to deep vein thrombosis (DVT) who are eligible for treatment.
The group in the trial
- Single ArmOther group
Use of Indigo Aspiration System in patients with obstruction due to DVT
Treatment: Indigo Aspiration System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- BOLT-DVT: A Prospective, Multicenter Study of Patients With Deep Vein Thrombosis to Evaluate the Safety and Efficacy of the Indigo® Aspiration System
- Record updated
- 8 September 2026